JSPR Q4 2023 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$23M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$18M

Net Income

-$17M

EPS (Diluted)

$-1.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$95M

Total Liabilities

$16M

Stockholders' Equity

$78M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$18M	-$14M	-28.9%
Net Income	-$17M	-$13M	-25.5%